DIESE MELDUNG PER E-MAIL VERSENDEN
Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases
*
marks required fields
Name des Empfängers:
*
E-Mail des Empfängers:
Nachricht:
*
Enter security words: